Skip to main content

Advertisement

Springer Nature Link
Log in

Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy

  • Original Research Article
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Background

Childhood cerebral adrenoleukodystrophy (CCALD), a progressive demyelinating disease affecting school-aged boys, causes death within a few years. Oxidative stress is an important contributing factor. N-acetylcysteine (NAC; 280 mg/kg/day) added as adjunctive therapy to reduced-intensity hematopoietic cell transplantation (HCT) improves survival in advanced cases. However, the mechanisms underlying the benefits of NAC are unclear.

Objective

The aim of this study was to understand the mechanism of action of NAC in the setting of HCT in CCALD.

Methods

Immunoassays were carried out to determine changes in heme oxygenase-1 (HO-1) and ferritin expression in plasma samples collected from boys with CCALD at three different timepoints during the course of transplantation. In addition, the induction of HO-1 was also confirmed in normal fibroblasts following incubation with 10–100 µmol/L NAC for 4 h.

Results

Following NAC therapy we observed an increase in expression of the antioxidants HO-1 (~4-fold) and its effector ferritin (~160-fold) in patient samples as compared with baseline. We also observed that NAC exposure significantly increased HO-1 expression in fibroblasts.

Conclusion

Our data suggest that HO-1 is a possible target protein of NAC and a mediator of its cytoprotective effects in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Santosh Rai PV, Suresh BV, Bhat IG, Sekhar M, Chakraborti S. Childhood adrenoleukodystrophy—classic and variant—review of clinical manifestations and magnetic resonance imaging. J Pediatr Neurosci. 2013;8(3):192–7. doi:10.4103/1817-1745.123661.

  2. Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta. 2004;1688(1):26–32. doi:10.1016/j.bbadis.2003.10.004.

    Article  CAS  PubMed  Google Scholar 

  3. Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol. 2005;64(12):1067–79. doi:10.1097/01.jnen.0000190064.28559.a4.

    Article  CAS  PubMed  Google Scholar 

  4. Deon M, Marchetti DP, Donida B, Wajner M, Vargas C. Oxidative stress in patients with X-linked adrenoleukodystrophy. Cell Mol Neurobiol. 2015. doi:10.1007/s10571-015-0234-2 (Epub 2015 Jul 14).

    PubMed  Google Scholar 

  5. Petrillo S, Piemonte F, Pastore A, Tozzi G, Aiello C, Pujol A, et al. Glutathione imbalance in patients with X-linked adrenoleukodystrophy. Mol Genet Metab. 2013;109(4):366–70. doi:10.1016/j.ymgme.2013.05.009.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Lopez-Erauskin J, Galino J, Bianchi P, Fourcade S, Andreu AL, Ferrer I, et al. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. Brain. 2012;135(Pt 12):3584–98. doi:10.1093/brain/aws292.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976;26(4):851–60.

    Article  CAS  PubMed  Google Scholar 

  8. Kapelushnik J, Varadi G, Nagler A. Matched unrelated human umbilical cord blood transplantation for X-linked adrenoleukodystrophy. J Pediatr Hematol Oncol. 1998;20(3):257–9.

    Article  CAS  PubMed  Google Scholar 

  9. Suzuki Y, Isogai K, Teramoto T, Tashita H, Shimozawa N, Nishimura M, et al. Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy. J Inherit Metab Dis. 2000;23(5):453–8.

    Article  CAS  PubMed  Google Scholar 

  10. Resnick IB, Abdul Hai A, Shapira MY, Bitan M, Hershkovitz E, Schwartz A, et al. Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen. Clin Transplant. 2005;19(6):840–7. doi:10.1111/j.1399-0012.2005.00411.x.

    Article  PubMed  Google Scholar 

  11. Ringden O, Remberger M, Svahn BM, Barkholt L, Mattsson J, Aschan J, et al. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center. Transplantation. 2006;81(5):718–25. doi:10.1097/01.tp.0000181457.43146.36.

    Article  PubMed  Google Scholar 

  12. Beam D, Poe MD, Provenzale JM, Szabolcs P, Martin PL, Prasad V, et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant. 2007;13(6):665–74. doi:10.1016/j.bbmt.2007.01.082.

    Article  PubMed  Google Scholar 

  13. Miller WP, Rothman SM, Nascene D, Kivisto T, DeFor TE, Ziegler RS, et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011;118(7):1971–8. doi:10.1182/blood-2011-01-329235.

    Article  CAS  PubMed  Google Scholar 

  14. Tolar J, Orchard PJ, Bjoraker KJ, Ziegler RS, Shapiro EG, Charnas L. N-Acetyl-l-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant. 2007;39(4):211–5. doi:10.1038/sj.bmt.1705571.

    Article  CAS  PubMed  Google Scholar 

  15. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003;60(1):6–20.

    Article  CAS  PubMed  Google Scholar 

  16. Marchetti DP, Donida B, da Rosa HT, Manini PR, Moura DJ, Saffi J, et al. Protective effect of antioxidants on DNA damage in leukocytes from X-linked adrenoleukodystrophy patients. Int J Dev Neurosci. 2015;43:8–15. doi:10.1016/j.ijdevneu.2015.03.004.

    Article  CAS  PubMed  Google Scholar 

  17. Galino J, Ruiz M, Fourcade S, Schluter A, Lopez-Erauskin J, Guilera C, et al. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal. 2011;15(8):2095–107. doi:10.1089/ars.2010.3877.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Lopez-Erauskin J, Fourcade S, Galino J, Ruiz M, Schluter A, Naudi A, et al. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol. 2011;70(1):84–92. doi:10.1002/ana.22363.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A, Jove M, et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet. 2008;17(12):1762–73. doi:10.1093/hmg/ddn085.

    Article  CAS  PubMed  Google Scholar 

  20. Masonic Cancer Center, University of Minnesota. Treatment of high risk, inherited lysosomal and peroxisomal disorders by reduced intensity hematopoietic stem cell transplantation [ClinicalTrials.gov identifier NCT00383448]. US National Institutes of Health, ClinicalTrials.gov. https://www.clinicaltrials.gov. Accessed 25 Nov 2015.

  21. Bao W, Rong S, Zhang M, Yu X, Zhao Y, Xiao X, et al. Plasma heme oxygenase-1 concentration in relation to impaired glucose regulation in a non-diabetic Chinese population. PLoS One. 2012;7(3):e32223. doi:10.1371/journal.pone.0032223.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Billings IF, Yu C, Byrne JG, Petracek MR, Pretorius M. Heme oxygenase-1 and acute kidney injury following cardiac surgery. Cardiorenal Med. 2014;4(1):12–21. doi:10.1159/000357871.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Mateo I, Infante J, Sanchez-Juan P, Garcia-Gorostiaga I, Rodriguez-Rodriguez E, Vazquez-Higuera JL, et al. Serum heme oxygenase-1 levels are increased in Parkinson’s disease but not in Alzheimer’s disease. Acta Neurol Scand. 2010;121(2):136–8. doi:10.1111/j.1600-0404.2009.01261.x.

    Article  CAS  PubMed  Google Scholar 

  24. Bharucha AE, Kulkarni A, Choi KM, Camilleri M, Lempke M, Brunn GJ, et al. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther. 2010;87(2):187–90. doi:10.1038/clpt.2009.221.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Atkuri KR, Mantovani JJ, Herzenberg LA. N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355–9. doi:10.1016/j.coph.2007.04.005.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Zhou J, Coles LD, Kartha RV, Nash N, Mishra U, Lund TC, et al. Intravenous administration of stable-labeled N-acetylcysteine demonstrates an indirect mechanism for boosting glutathione and improving redox status. J Pharm Sci. 2015;104(8):2619–26. doi:10.1002/jps.24482.

    Article  CAS  PubMed  Google Scholar 

  27. Radtke KK, Coles LD, Mishra U, Orchard PJ, Holmay M, Cloyd JC. Interaction of N-acetylcysteine and cysteine in human plasma. J Pharm Sci. 2012;101(12):4653–9. doi:10.1002/jps.23325.

    Article  CAS  PubMed  Google Scholar 

  28. Ewing P, Hildebrandt GC, Planke S, Andreesen R, Holler E, Gerbitz A. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation. Int J Mol Med. 2007;20(3):301–8.

    CAS  PubMed  Google Scholar 

  29. Gerbitz A, Ewing P, Wilke A, Schubert T, Eissner G, Dietl B, et al. Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2004;10(7):461–72. doi:10.1016/j.bbmt.2004.04.001.

    Article  CAS  PubMed  Google Scholar 

  30. Bach FH. Heme oxygenase-1 and transplantation tolerance. Hum Immunol. 2006;67(6):430–2. doi:10.1016/j.humimm.2006.03.006.

    Article  CAS  PubMed  Google Scholar 

  31. Rockenbach FJ, Deon M, Marchese DP, Manfredini V, Mescka C, Ribas GS, et al. The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy. Mol Genet Metab. 2012;106(2):231–6. doi:10.1016/j.ymgme.2012.03.019.

    Article  CAS  PubMed  Google Scholar 

  32. Schipper HM, Gupta A, Szarek WA. Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Curr Alzheimer Res. 2009;6(5):424–30. doi:10.2174/156720509789207985.

    Article  CAS  PubMed  Google Scholar 

  33. Or R, Matzner Y, Konijn AM. Serum ferritin in patients undergoing bone marrow transplantation. Cancer. 1987;60(5):1127–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author contributions

Designed the experiments: RVK, JZ, LB, HS, PJO, JC. Performed the experiments: JZ, RVK, LB. Analyzed the data: JZ, RVK, LB, HS. Contributed essential reagents/tools: PJO, JC, HS. Wrote the paper: RVK, JZ, LB, HS, PJO, JC.

Author information

Author notes

    Authors and Affiliations

    1. Department of Experimental and Clinical Pharmacology, Center for Orphan Drug Research, University of Minnesota, Minneapolis, MN, USA

      Reena V. Kartha, Jie Zhou & James Cloyd

    2. Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA

      Henning Schröder

    3. Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA

      Lisa Basso & Paul J. Orchard

    4. University of Minnesota, Room 4-214, McGuire Translational Research Facility, 2001-6th Street SE, Minneapolis, MN, 55455, USA

      Reena V. Kartha

    Authors
    1. Reena V. Kartha
      View author publications

      You can also search for this author inPubMed Google Scholar

    2. Jie Zhou
      View author publications

      You can also search for this author inPubMed Google Scholar

    3. Lisa Basso
      View author publications

      You can also search for this author inPubMed Google Scholar

    4. Henning Schröder
      View author publications

      You can also search for this author inPubMed Google Scholar

    5. Paul J. Orchard
      View author publications

      You can also search for this author inPubMed Google Scholar

    6. James Cloyd
      View author publications

      You can also search for this author inPubMed Google Scholar

    Corresponding author

    Correspondence to Reena V. Kartha.

    Ethics declarations

    Funding

    The study was funded by a University of Minnesota Academic Health Center Faculty Development Grant to JC and PJO.

    Conflict of interest

    RVK, JZ, LB, HS, PJO, and JC declare that they have no conflicts of interest.

    Ethical approval

    All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

    Additional information

    R. V. Kartha and J. Zhou contributed equally to this work.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    Supplementary material 1 (PDF 134 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Kartha, R.V., Zhou, J., Basso, L. et al. Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy. CNS Drugs 29, 1041–1047 (2015). https://doi.org/10.1007/s40263-015-0300-9

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40263-015-0300-9

    Keywords